The entire cohort of 507 patients from the INCEPTION database were included, which consisted of HER2+ breast cancer patients being treated with trastuzumab and other cancer therapies including surgery, chemotherapy, and radiotherapy. This evidence concerns the gene ERBB2 and breast cancer.